Prednisolone has the same cardiovascular risk profile as hydrocortisone in glucocorticoid replacement
Introduction: Patients who need glucocorticoid replacement in both primary and secondary adrenal insufficiency (AI) have the choice of either once-daily prednisolone or thrice-daily hydrocortisone. A recent European study found no difference between prednisolone and hydrocortisone users in several m...
Main Authors: | David J F Smith, Hemanth Prabhudev, Sirazum Choudhury, Karim Meeran |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2017-10-01
|
Series: | Endocrine Connections |
Subjects: | |
Online Access: | http://www.endocrineconnections.com/content/6/8/766.full |
Similar Items
-
The use of prednisolone versus dual-release hydrocortisone in the treatment of hypoadrenalism
by: Sirazum Choudhury, et al.
Published: (2021-03-01) -
Dual-release hydrocortisone vs conventional glucocorticoids in adrenal insufficiency
by: V Guarnotta, et al.
Published: (2019-06-01) -
Early Metabolic Benefits of Switching Hydrocortisone to Modified Release Hydrocortisone in Adult Adrenal Insufficiency
by: Christopher A. M. Bannon, et al.
Published: (2021-03-01) -
Prednisolone is associated with a worse bone mineral density in primary adrenal insufficiency
by: Kathrin R Frey, et al.
Published: (2018-06-01) -
Comparison of different glucocorticoid regimens in the management of classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
by: T P Ajish, et al.
Published: (2014-01-01)